Clinical Effectiveness of Late Maxillary Protraction for Cleft Lip and Palate
PROTRACTSURG
1 other identifier
observational
117
1 country
2
Brief Summary
Patients with cleft lip and palate frequently develop Class III (Cl III) malocclusions or underbites following early cleft repair surgeries. This clinical trial compares the current standard of care for treating the Cl III malocclusion, orthognathic (jaw) surgery after pubertal growth (16-21 years), with an alternative orthopedic approach to protract the maxilla during adolescence (11-14 years). At Children's Hospital Los Angeles(CHLA), early adolescents with cleft lip and palate and Cl III malocclusion are offered an alternative non-surgical approach to correct the malocclusion called "maxillary protraction". Prior to age 14, the maxillary sutures have not fused and can be mobilized by alternating weekly expansion and constriction with a rapid palatal expander (RPE), thereby allowing the upper jaw (maxilla) to be pulled forward (protracted) to correct the underbite. This prospective parallel cohort study will assess the patients undergoing treatment for the Cl III malocclusion by either orthognathic surgery or maxillary protraction at four data collection time points during treatment. The data includes digitized study models, photographs and radiographs, quality of life surveys (SF12, YQOL), parent surveys (ASEBA), treatment cost, periodontal measurements and treatment complications. The study design is a descriptive cohort study that examines the success of treatment (% not requiring a second surgery), the dental and skeletal changes associated with treatment, the stability of treatment and the behavioural/adaptive factors (ASEBA) that contribute to success and lack of success for each treatment. The primary trial will be conducted at Children's Hospital Los Angeles and a pilot study to confirm translation to different settings will be conducted at Seattle Children's Hospital.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2015
Longer than P75 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 29, 2015
CompletedFirst Submitted
Initial submission to the registry
May 9, 2016
CompletedFirst Posted
Study publicly available on registry
June 3, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2021
CompletedOctober 11, 2021
October 1, 2021
6.1 years
May 9, 2016
October 4, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bite correction of digitized models.
The metric for comparing the difference in bite using study models from patients with cleft lip and palate is the "GOSLON Yardstick" which can rate antero-posterior as well as transverse positions.
Approximately 36-48 months for maxillary protraction patients and approximately 36-42 months for patients undergoing orthognathic surgery.
Secondary Outcomes (7)
Cephalometric radiographs
The four timepoints during approximately 36-48 months for maxillary protraction patients and approximately 36-42 months for patients undergoing orthognathic surgery.
Facial attractive rating of photographs
The four timepoints during approximately 36-48 months for maxillary protraction patients and approximately 36-42 months for patients undergoing orthognathic surgery.
Costs of treatments
At the end of approximately 36-48 months for maxillary protraction patients and approximately 36-42 months for patients undergoing orthognathic surgery.
12-Item Short Form Health Survey (SF-12) developed by the Rand Corporation
The four timepoints during approximately 36-48 months for maxillary protraction patients and approximately 36-42 months for patients undergoing orthognathic surgery.
Youth Quality of Life (YQOL) survey designed by the Seattle Quality of Life Group
The four timepoints during approximately 36-48 months for maxillary protraction patients and approximately 36-42 months for patients undergoing orthognathic surgery.
- +2 more secondary outcomes
Study Arms (2)
Maxillary protraction
Early adolescents (11 - 14 yrs) with cleft lip and palate and Cl III malocclusion
Orthognathic surgery
Late adolescents to young adults (16-21 years) with cleft lip and palate and Cl III malocclusion
Interventions
"Maxillary protraction" is an alternative non-surgical approach to correct the Cl III malocclusion. At ages 11- 14, the maxillary sutures have not fused and can be mobilized by alternating weekly expansion and constriction with a rapid palatal expander (RPE), thereby allowing the maxilla to be protracted in order to correct the underbite. This treatment is offered to the patients, age 11-14, who have the Cl III malocclusion with or without cleft lip and palate.
The orthognathic surgery is the current standard of care for treating the Cl III malocclusion after pubertal growth. This treatment is offered to the patients, after pubertal growth, who have the Cl III malocclusion with or without cleft lip and palate.
Eligibility Criteria
Patients with nonsyndromic cleft lip and palate who have a Cl III malocclusion
You may qualify if:
- Diagnosis of nonsyndromic cleft lip and palate and Class III malocclusion
- Age 11-14 for maxillary protraction, Age 16-21 for LeFort I single jaw surgery.
You may not qualify if:
- Cognitive delay;
- Mandibular asymmetry;
- Mandibular prognathism;
- jaw cants;
- Non-grafted alveolar cleft;
- Inability or unwillingness to have clinical radiographs, photographs, or dental impressions taken;
- History of therapeeutic radiation treatment to the mazilla or mandible;
- Pregnancy; if participants become pregnant during the study they will be withdrawn.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Californialead
- Seattle Children's Hospitalcollaborator
- Children's Hospital Los Angelescollaborator
Study Sites (2)
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Seattle Children's Hospital
Seattle, Washington, 981105, United States
Related Publications (4)
Chung EH, Borzabadi-Farahani A, Yen SL. Clinicians and laypeople assessment of facial attractiveness in patients with cleft lip and palate treated with LeFort I surgery or late maxillary protraction. Int J Pediatr Otorhinolaryngol. 2013 Sep;77(9):1446-50. doi: 10.1016/j.ijporl.2013.05.042. Epub 2013 Jul 18.
PMID: 23871270BACKGROUNDYen SL. Protocols for Late Maxillary Protraction in Cleft Lip and Palate Patients at Childrens Hospital Los Angeles. Semin Orthod. 2011 Jun 1;17(2):138-148. doi: 10.1053/j.sodo.2011.01.001.
PMID: 21765629BACKGROUNDMcIlvaine E, Borzabadi-Farahani A, Lane CJ, Azen SP, Yen SL. Apriori feasibility testing of randomized clinical trial design in patients with cleft deformities and Class III malocclusion. Int J Pediatr Otorhinolaryngol. 2014 May;78(5):725-30. doi: 10.1016/j.ijporl.2014.01.006. Epub 2014 Feb 12.
PMID: 24630053BACKGROUNDBorzabadi-Farahani A, Lane CJ, Yen SL. Late maxillary protraction in patients with unilateral cleft lip and palate: a retrospective study. Cleft Palate Craniofac J. 2014 Jan;51(1):e1-e10. doi: 10.1597/12-099. Epub 2012 Dec 13.
PMID: 23237432RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephen Yen, DMD, PhD
CHLA
- STUDY DIRECTOR
Jane Atkinson
National Institute of Dental and Craniofacial Research (NIDCR)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
May 9, 2016
First Posted
June 3, 2016
Study Start
April 29, 2015
Primary Completion
May 31, 2021
Study Completion
May 31, 2021
Last Updated
October 11, 2021
Record last verified: 2021-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Beginning 3 months and ending 5 years following article publication
- Access Criteria
- Researchers who provide a methodologically sound proposal.
All of the participant data collected during the trial after deidentification